NasdaqCM - Nasdaq Real Time Price USD
Marker Therapeutics, Inc. (MRKR)
1.1630
-0.0270
(-2.27%)
As of 9:37:21 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.06M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ELMS STEVEN A Director | Purchase at price 3.20 per share. | Indirect | 35,472 | Dec 23, 2024 |
| NEW ENTERPRISE ASSOCIATES 16, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.20 per share. | Indirect | 1,773,600 | Dec 23, 2024 |
Related Tickers
DSGN Design Therapeutics, Inc.
4.0350
-0.86%
NTRB Nutriband Inc.
5.44
+4.41%
RAPT RAPT Therapeutics, Inc.
0.8590
-0.65%
ATXI Avenue Therapeutics, Inc.
0.2580
-4.44%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.68
-3.40%
VYNE VYNE Therapeutics Inc.
1.8900
+2.72%
REVB Revelation Biosciences, Inc.
2.8200
-0.35%
BDRX Biodexa Pharmaceuticals Plc
1.4600
+2.82%
PMVP PMV Pharmaceuticals, Inc.
1.0600
-0.93%
GHRS GH Research PLC
9.35
-1.58%